A Study Evaluating the Efficacy and Impact on Health-related Quality of Life of Levocetirizine in Adults With Seasonal Allergic Rhinitis

PHASE4CompletedINTERVENTIONAL
Enrollment

580

Participants

Timeline

Start Date

April 30, 2008

Primary Completion Date

July 31, 2008

Study Completion Date

July 31, 2008

Conditions
Seasonal Allergic Rhinitis
Interventions
DRUG

levocetirizine dihydrochloride

5 mg daily (oral tablet) for 14 days

DRUG

placebo

0 mg daily (matching oral tablet) for 14 days

Trial Locations (38)

Unknown

Tucson

Los Angeles

Sacramento

San Francisco

San Jose

Colorado Springs

Denver

Miami

Atlanta

Gainesville

Lawrenceville

Stockbridge

Normal

Louisville

Harvard

North Dartmouth

Novi

Minneapolis

Berlin

Skillman

Verona

Rochester

Asheville

Charlotte

Wilmington

Cincinnati

Edmond

Oklahoma City

Portland

Pittsburgh

Upland

Lincoln

Germantown

San Antonio

Salt Lake City

South Burlington

Arlington

Milwaukee

Sponsors

Lead Sponsor

All Listed Sponsors
lead

UCB Pharma

INDUSTRY